MedTrace Logo

CRRT for Glutamate Elimination After Cardiac Arrest

NCT02963298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-06-21

No results posted yet for this study

Summary

Glutamate is known to be a mediator for apoptosis after brain hypoxia e.g. due to cardiac arrest. This pilot trial evaluates the possibility of elimination of Glutamate by CRRT after cardiac arrest.

Conditions

  • Reperfusion Syndrome

Interventions

PROCEDURE

Continuous renal replacement therapy

Sponsors & Collaborators

  • C. Storm

    lead OTHER

Principal Investigators

  • Christian Storm, MD · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-09-06
Completion
2017-09-06

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963298 on ClinicalTrials.gov